Dr. Ulrike Riegler
Prior to founding Riegler & Klar Pharma-Consulting GbR, we worked together for more than 10 years at Brinker Pharma GmbH as Regulatory Affairs Managers, where we supervised marketing authorisation procedures as project managers. Our focus is on the preparation of quality documentation for pharmaceuticals (CMC dossiers) and in labelling, respectively.
Dr. Sandra Mahr
PhD (Biology). M.D.R.A.
On 1st July 2018, I joined Riegler-Klar & Partner Pharma-Consulting GbR as a managing director. I have several years’ experience as Regulatory Affairs Manager at Brinker Pharma GmbH (later Xendo Deutschland GmbH) where in addition to the preparation of the clinical documentation for registration dossiers, I was responsible for the supervision of marketing authorisation procedures. Before joining the area of drug regulatory affairs, I worked in drug development. My focus is on both the preparation of the clinical documentation for pharmaceuticals (clinical dossiers) and the product information.Gilda Gordon
BSc (Chemistry). M.D.R.A.
I joined Riegler-Klar & Partner Pharma-Consulting GbR in 2019. I have 10 years’ experience in Regulatory Affairs and worked as a Regulatory Affairs Manager at Brinker Pharma GmbH (later Xendo Deutschland GmbH) where I was responsible for the lifecycle maintenance of medicinal products: from the preparation and submission of original Marketing Authorisation Applications up to national approvals, and preparation and submission of Variations, Repeat Use Procedures and Renewals. Before joining the area of drug regulatory affairs, I worked in the international pharmaceutical industry both in Quality Control and Research and Development as a chemist. My focus is the country-specific national requirements and preparation of Module 1.